Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players

PR Newswire January 25, 2017

CEO Note - Clinical Study Update and a Review of 2016 Accomplishments

PR Newswire January 11, 2017

Passage of the 21st Century Cures Act and its Potential Implications on Biodefense

PR Newswire December 21, 2016

Aethlon Announces Initiation of Sepsis-Related Virus Study

PR Newswire December 15, 2016

Aethlon Medical Announces Fiscal 2017 Second Quarter Results

PR Newswire November 10, 2016

Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016

PR Newswire November 3, 2016

Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation

PR Newswire October 13, 2016

Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum

PR Newswire October 12, 2016

12 Biggest Mid-Day Losers For Friday

Benzinga.com  August 12, 2016

Aethlon Medical Announces Fiscal 2016 Results

PR Newswire June 29, 2016

Earnings Scheduled For June 29, 2016

Benzinga.com  June 29, 2016

Aethlon Medical Announces $12.5 Million At The Market Program

PR Newswire June 28, 2016

Aethlon Medical Joins Russell Microcap® Index

PR Newswire June 27, 2016

Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016

PR Newswire June 27, 2016

Aethlon Medical Set To Join Russell Microcap® Index

PR Newswire June 22, 2016

Aethlon Medical Announces Issuance Of Exosome Capture Patent

PR Newswire June 14, 2016

Aethlon Medical To Present Cancer And Infectious Disease Initiatives, As Well As Chronic Traumatic Encephalopathy (CTE) Candidate Biomarker Discovery At Tomorrow's BIO International Convention

PR Newswire June 6, 2016

Aethlon Medical To Present At 2nd Annual Sachs Associates Immuno-oncology: BD&L And Investment Forum On June 3, 2016

PR Newswire June 1, 2016

Aethlon Medical's CEO and Executive Chairman James Joyce Interviewed by The Life Sciences Report

Marketwired May 5, 2016

Aethlon Medical's Exosome Sciences Announces Production of ELLSA Exosome Isolation Platform

PR Newswire May 4, 2016